These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
130 related items for PubMed ID: 22104156
1. Feasibility of involved-field conformal radiotherapy for cervical and upper-thoracic esophageal cancer. Ma JB, Song YP, Yu JM, Zhou W, Cheng EC, Zhang XQ, Kong L. Onkologie; 2011; 34(11):599-604. PubMed ID: 22104156 [Abstract] [Full Text] [Related]
2. [Involved-field three-dimensional conformal radiation treatment for stage III non-small-cell lung]. Yu JM, Sun XD, Li MH, Zhang JD, Yao CP, Liu S, Zhang Z. Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):526-9. PubMed ID: 17147119 [Abstract] [Full Text] [Related]
3. A randomized study of involved-field irradiation versus elective nodal irradiation in combination with concurrent chemotherapy for inoperable stage III nonsmall cell lung cancer. Yuan S, Sun X, Li M, Yu J, Ren R, Yu Y, Li J, Liu X, Wang R, Li B, Kong L, Yin Y. Am J Clin Oncol; 2007 Jun; 30(3):239-44. PubMed ID: 17551299 [Abstract] [Full Text] [Related]
4. Patterns of failure after involved field radiotherapy for locally advanced esophageal squamous cell carcinoma. Li DJ, Li HW, He B, Wang GM, Cai HF, Duan SM, Liu JJ, Zhang YJ, Cui Z, Jiang H. J BUON; 2016 Jun; 21(5):1268-1273. PubMed ID: 27837632 [Abstract] [Full Text] [Related]
5. Three-dimensional conformal radiation therapy for esophageal squamous cell carcinoma: is elective nodal irradiation necessary? Zhao KL, Ma JB, Liu G, Wu KL, Shi XH, Jiang GL. Int J Radiat Oncol Biol Phys; 2010 Feb 01; 76(2):446-51. PubMed ID: 20004527 [Abstract] [Full Text] [Related]
6. Retrospective analysis of outcome differences in preoperative concurrent chemoradiation with or without elective nodal irradiation for esophageal squamous cell carcinoma. Hsu FM, Lee JM, Huang PM, Lin CC, Hsu CH, Tsai YC, Lee YC, Chia-Hsien Cheng J. Int J Radiat Oncol Biol Phys; 2011 Nov 15; 81(4):e593-9. PubMed ID: 21658851 [Abstract] [Full Text] [Related]
10. Involved-field radiotherapy (IFRT) versus elective nodal irradiation (ENI) in combination with concurrent chemotherapy for 239 esophageal cancers: a single institutional retrospective study. Yamashita H, Takenaka R, Omori M, Imae T, Okuma K, Ohtomo K, Nakagawa K. Radiat Oncol; 2015 Aug 14; 10():171. PubMed ID: 26269033 [Abstract] [Full Text] [Related]
11. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients. Liao Z, Zhang Z, Jin J, Ajani JA, Swisher SG, Stevens CW, Ho L, Smythe R, Vaporciyan AA, Putnam JB, Walsh GL, Roth JA, Yao JC, Allen PK, Cox JD, Komaki R. Int J Radiat Oncol Biol Phys; 2004 Dec 01; 60(5):1484-93. PubMed ID: 15590179 [Abstract] [Full Text] [Related]
13. Elective nodal irradiation (ENI) vs. involved field radiotherapy (IFRT) for locally advanced non-small cell lung cancer (NSCLC): A comparative analysis of toxicities and clinical outcomes. Fernandes AT, Shen J, Finlay J, Mitra N, Evans T, Stevenson J, Langer C, Lin L, Hahn S, Glatstein E, Rengan R. Radiother Oncol; 2010 May 01; 95(2):178-84. PubMed ID: 20356642 [Abstract] [Full Text] [Related]
14. Freedom from local and regional failure of contralateral neck with ipsilateral neck radiotherapy for node-positive tonsil cancer: results of a prospective management approach. Rusthoven KE, Raben D, Schneider C, Witt R, Sammons S, Raben A. Int J Radiat Oncol Biol Phys; 2009 Aug 01; 74(5):1365-70. PubMed ID: 19168295 [Abstract] [Full Text] [Related]
17. Elective nodal irradiation or involved-field irradiation in definitive chemoradiotherapy for esophageal squamous cell cancer: a retrospective analysis in clinical N0 patients. Sun Y, Zhang XL, Mao QF, Liu YH, Kong L, Li MH. Curr Oncol; 2018 Oct 01; 25(5):e423-e429. PubMed ID: 30464693 [Abstract] [Full Text] [Related]
18. Number and location of positive nodes, postoperative radiotherapy, and survival after esophagectomy with three-field lymph node dissection for thoracic esophageal squamous cell carcinoma. Chen J, Pan J, Zheng X, Zhu K, Li J, Chen M, Wang J, Liao Z. Int J Radiat Oncol Biol Phys; 2012 Jan 01; 82(1):475-82. PubMed ID: 20934269 [Abstract] [Full Text] [Related]